TCL Archive Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL December 31, 2010
TCL Archive Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational October 10, 2014
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
TCL Archive Interim Funding: Noncompeting Renewals Reduced By 4 Percent, Competing Current Plus 7 Percent January 8, 1982